AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding AIM ImmunoTech Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 18 | 18 | 0 |
| Shares | 175.8K | 1.15M | +971.6K (+552.8%) |
| Value | $102.8K | $325.6K | +$222.7K (+216.7%) |
New holders (4)
Institutions that held AIM ImmunoTech Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 32,444 | $9.21K | 0.00% |
| Susquehanna International Group, LLP | 21,859 | $6.21K | 0.00% |
| Ground Swell Capital, LLC | 12,222 | $3.47K | 0.00% |
| Continuum Advisory, LLC | 500 | $142 | 0.00% |
Sold out (4)
Institutions that held AIM ImmunoTech Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| HRT Financial LP | 26,032 | $15.0K |
| XTX Topco Ltd | 20,590 | $12.0K |
| GWM Advisors LLC | 5,000 | $2.92K |
| Steward Partners Investment Advisory, LLC | 2 | $1 |